论文信息 - Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research. - 字舞流文

Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research.

V. A. Stewart | J. Haynes | Joe D. Cohen | O. Ofori-Anyinam | A. Magill | C. Ockenhouse | W. Ballou | K. Kester | D. Lanar | S. Dutta | D. Heppner | C. Diggs | L. Soisson | J. Cummings | M. Dubois | U. Krzych | C. Brando | A. Barbosa | M. Polhemus | L. Ware | R. Bowden | Sally A Robinson | Els De-Kock